Company / SG&A Expense
STANDARD BIOTOOLS INC. SG&A Expense History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A Expense
$87.5M
FY2025
5-year range
$84.5M / $102.3M
FY2021-FY2025
Trend
-14.4%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $102M to $88M over the past 2 years.
Based on SEC 10-K filings.
$88M in FY2025 with a 5-year CAGR of +1.9%.
Improved from $102M to $88M over the past 2 years.
SG&A Expense over time
Growth rates
- 3-Year CAGR
- -4.0%
- 5-Year CAGR
- +1.9%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +1.9%, indicating consistent growth.
- In FY2025, sg&a expense decreased 14.4% year-over-year.
- Peak sg&a expense was recorded in FY2024.
- Lowest sg&a expense in the period was in FY2016.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $87.5M | -14.4% |
| FY2024 | $102.3M | +0.0% |
| FY2023 | $102.3M | +3.4% |
| FY2022 | $98.9M | +17.1% |
| FY2021 | $84.5M | +5.9% |
| FY2020 | $79.8M | +0.3% |
| FY2019 | $79.5M | -14.7% |
| FY2018 | $93.2M | +12.4% |
| FY2017 | $83.0M | +16.3% |
| FY2016 | $71.3M | +47.3% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026